These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 86624)

  • 41. Eyelid squamous cell carcinoma in situ treated with topical 5-fluorouracil.
    Sharkawi E; Hamedani M; Fouladi M
    Clin Exp Ophthalmol; 2011 Dec; 39(9):915-6. PubMed ID: 22128812
    [No Abstract]   [Full Text] [Related]  

  • 42. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa.
    Souza CS; Felício LB; Bentley MV; Tedesco AC; Ferreira J; Kurachi C; Bagnato VS
    Br J Dermatol; 2005 Sep; 153(3):672-4. PubMed ID: 16120168
    [No Abstract]   [Full Text] [Related]  

  • 43. [Studies on the clinical effect of NK 631 for oral-cavity cancers (author's transl)].
    Ohashi Y; Abe M; Saito K; Mizutani H; Onishi S; Ueda N
    Jpn J Antibiot; 1979 Feb; 32(2):259-64. PubMed ID: 86622
    [No Abstract]   [Full Text] [Related]  

  • 44. Multiple Bowen's disease of the fingers.
    Ota M; Kawashima M; Mitsuishi T
    Eur J Dermatol; 2002; 12(3):275-7. PubMed ID: 11978572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
    Stables GI; Stringer MR; Robinson DJ; Ash DV
    Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective photodynamic therapy of actinic keratoses and Bowen's disease using microneedle perforation.
    Kolde G; Rowe E; Meffert H
    Br J Dermatol; 2013 Feb; 168(2):450-2. PubMed ID: 22804095
    [No Abstract]   [Full Text] [Related]  

  • 47. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre.
    Moseley H; Ibbotson S; Woods J; Brancaleon L; Lesar A; Goodman C; Ferguson J
    Lasers Surg Med; 2006 Jun; 38(5):403-16. PubMed ID: 16788933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of cutaneous malignancies with topically applied cycloheximide.
    du Vivier A
    Br J Dermatol; 1979 Aug; 101(2):167-9. PubMed ID: 486324
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linear porokeratosis with multiple squamous cell carcinomas successfully treated by electrochemotherapy.
    Sommerlad M; Lock A; Moir G; McGregor J; Bull R; Cerio R; Harwood C
    Br J Dermatol; 2016 Dec; 175(6):1342-1345. PubMed ID: 27086492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Preoperative application of NK 631 for carcinoma of oral cavity (author's transl)].
    Yamamoto E; Sunakawa H; Kohama GI
    Jpn J Antibiot; 1979 Feb; 32(2):253-8. PubMed ID: 86621
    [No Abstract]   [Full Text] [Related]  

  • 52. [Phase I and phase II studies of a new bleomycin (pepleomycin) (author's transl)].
    Miura T; Katayama K; Wada T
    Jpn J Antibiot; 1979 Feb; 32(2):265-77. PubMed ID: 86623
    [No Abstract]   [Full Text] [Related]  

  • 53. [Primary effect of NK 631 against head-and-neck cancers (author's transl)].
    Takata K; Honda T
    Jpn J Antibiot; 1979 Jan; 32(1):106-14. PubMed ID: 84880
    [No Abstract]   [Full Text] [Related]  

  • 54. Photodynamic therapy of skin and esophageal cancers.
    McCaughan JS
    Cancer Invest; 1990; 8(3-4):407-16. PubMed ID: 2207766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical effects of NK 631, a new bleomycin derivative, in treatment of oral cancer (author's transl)].
    Kajiyama M; Dohjyo M; Ohno A; Nagasaka K; Yamaguma M; Okabe T; Terasaka S
    Jpn J Antibiot; 1979 Jan; 32(1):129-37. PubMed ID: 84883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical application of NK 631 to head-and-neck cancers (author's transl)].
    Ogawa Y; Omata T; Imaizumi H; Shiga H; Ouchi J
    Jpn J Antibiot; 1979 Jan; 32(1):115-20. PubMed ID: 84881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab].
    Delaitre L; Martins-Héricher J; Truchot E; Denis D; Prophette B; Maillard H; Bénéton-Benhard N
    Ann Dermatol Venereol; 2020 Apr; 147(4):279-284. PubMed ID: 31879092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The 'golden goddess' of spices: a potentially effective topical therapy for Bowen disease?
    Harper N; Saigal H; Kaur MR; Orpin S
    Clin Exp Dermatol; 2017 Jul; 42(5):545-547. PubMed ID: 28512989
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bleomycin: cellular and vascular alteration in a patient (author's transl)].
    Hagedorn M; Petres J; Mittermayer C
    Arch Dermatol Forsch; 1974 Jul; 250(1):71-80. PubMed ID: 4136308
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical application of NK 631 in the treatment of cancer of the tongue and the floor of the mouth (author's transl)].
    Hayashida K; Watanabe H; Ito M; Nakashima T; Toriya Y; Hiroto I; Jingu K; Hayabuchi N
    Jpn J Antibiot; 1979 Apr; 32(4):509-15. PubMed ID: 88531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.